Cargando…

An Intervention to Improve Medication Adherence in People With Heart Disease (Text4HeartII): Randomized Controlled Trial

BACKGROUND: Mobile health technologies have the potential to improve the reach and delivery of interventions for promoting long-term secondary prevention of coronary heart disease. OBJECTIVE: This study aims to determine the effectiveness of an SMS text messaging intervention (Text4HeartII) for impr...

Descripción completa

Detalles Bibliográficos
Autores principales: Maddison, Ralph, Jiang, Yannan, Stewart, Ralph, Scott, Tony, Kerr, Andrew, Whittaker, Robyn, Benatar, Jocelyn, Rolleston, Anna, Estabrooks, Paul, Dale, Leila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: JMIR Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262599/
https://www.ncbi.nlm.nih.gov/pubmed/34106081
http://dx.doi.org/10.2196/24952
_version_ 1783719216956833792
author Maddison, Ralph
Jiang, Yannan
Stewart, Ralph
Scott, Tony
Kerr, Andrew
Whittaker, Robyn
Benatar, Jocelyn
Rolleston, Anna
Estabrooks, Paul
Dale, Leila
author_facet Maddison, Ralph
Jiang, Yannan
Stewart, Ralph
Scott, Tony
Kerr, Andrew
Whittaker, Robyn
Benatar, Jocelyn
Rolleston, Anna
Estabrooks, Paul
Dale, Leila
author_sort Maddison, Ralph
collection PubMed
description BACKGROUND: Mobile health technologies have the potential to improve the reach and delivery of interventions for promoting long-term secondary prevention of coronary heart disease. OBJECTIVE: This study aims to determine the effectiveness of an SMS text messaging intervention (Text4HeartII) for improving adherence to medication and lifestyle changes over and above usual care in people with coronary heart disease at 24 and 52 weeks. METHODS: A two-arm, parallel, randomized controlled trial was conducted in New Zealand. Participants with a recent acute coronary syndrome were randomized to receive usual cardiac services alone (control, n=153) or a 24-week SMS text message program for supporting self-management plus usual cardiac services (n=153). The primary outcome was adherence to medication at 24 weeks, defined as a medication possession ratio of 80% or more for aspirin, statin, and antihypertensive therapy. Secondary outcomes included medication possession ratio at 52 weeks, self-reported medication adherence, adherence to healthy lifestyle behaviors, and health-related quality of life at 24 and 52 weeks. RESULTS: Participants were predominantly male (113/306, 80.3%) and European New Zealanders (210/306, 68.6%), with a mean age of 61 years (SD 11 years). Groups were comparable at baseline. National hospitalization and pharmacy dispensing records were available for all participants; 92% (282/306, 92.1%) of participants completed a 24-week questionnaire and 95.1% (291/306) of participants completed a 52-week questionnaire. Adherence with 3 medication classes were lower in the intervention group than in the control group (87/153, 56.8% vs 105/153, 68.6%, odds ratio 0.60, 95% CI 0.38-0.96; P=.03) and 52 weeks (104/153, 67.9% vs 83/153, 54.2%; odds ratio 0.56, 95% CI 0.35-0.89; P=.01). Self-reported medication adherence scores showed the same trend at 52 weeks (mean difference 0.3; 95% CI 0.01-0.59; P=.04). Moreover, self-reported adherence to health-related behaviors was similar between groups. CONCLUSIONS: Text4HeartII did not improve dispensed medication or adherence to a favorable lifestyle over and above usual care. This finding contrasts with previous studies and highlights that the benefits of text interventions may depend on the context in which they are used. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12616000422426; http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=370398. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.1186/s13063-018-2468-z
format Online
Article
Text
id pubmed-8262599
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher JMIR Publications
record_format MEDLINE/PubMed
spelling pubmed-82625992021-07-27 An Intervention to Improve Medication Adherence in People With Heart Disease (Text4HeartII): Randomized Controlled Trial Maddison, Ralph Jiang, Yannan Stewart, Ralph Scott, Tony Kerr, Andrew Whittaker, Robyn Benatar, Jocelyn Rolleston, Anna Estabrooks, Paul Dale, Leila JMIR Mhealth Uhealth Original Paper BACKGROUND: Mobile health technologies have the potential to improve the reach and delivery of interventions for promoting long-term secondary prevention of coronary heart disease. OBJECTIVE: This study aims to determine the effectiveness of an SMS text messaging intervention (Text4HeartII) for improving adherence to medication and lifestyle changes over and above usual care in people with coronary heart disease at 24 and 52 weeks. METHODS: A two-arm, parallel, randomized controlled trial was conducted in New Zealand. Participants with a recent acute coronary syndrome were randomized to receive usual cardiac services alone (control, n=153) or a 24-week SMS text message program for supporting self-management plus usual cardiac services (n=153). The primary outcome was adherence to medication at 24 weeks, defined as a medication possession ratio of 80% or more for aspirin, statin, and antihypertensive therapy. Secondary outcomes included medication possession ratio at 52 weeks, self-reported medication adherence, adherence to healthy lifestyle behaviors, and health-related quality of life at 24 and 52 weeks. RESULTS: Participants were predominantly male (113/306, 80.3%) and European New Zealanders (210/306, 68.6%), with a mean age of 61 years (SD 11 years). Groups were comparable at baseline. National hospitalization and pharmacy dispensing records were available for all participants; 92% (282/306, 92.1%) of participants completed a 24-week questionnaire and 95.1% (291/306) of participants completed a 52-week questionnaire. Adherence with 3 medication classes were lower in the intervention group than in the control group (87/153, 56.8% vs 105/153, 68.6%, odds ratio 0.60, 95% CI 0.38-0.96; P=.03) and 52 weeks (104/153, 67.9% vs 83/153, 54.2%; odds ratio 0.56, 95% CI 0.35-0.89; P=.01). Self-reported medication adherence scores showed the same trend at 52 weeks (mean difference 0.3; 95% CI 0.01-0.59; P=.04). Moreover, self-reported adherence to health-related behaviors was similar between groups. CONCLUSIONS: Text4HeartII did not improve dispensed medication or adherence to a favorable lifestyle over and above usual care. This finding contrasts with previous studies and highlights that the benefits of text interventions may depend on the context in which they are used. TRIAL REGISTRATION: Australian New Zealand Clinical Trials Registry ACTRN12616000422426; http://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=370398. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): RR2-10.1186/s13063-018-2468-z JMIR Publications 2021-06-09 /pmc/articles/PMC8262599/ /pubmed/34106081 http://dx.doi.org/10.2196/24952 Text en ©Ralph Maddison, Yannan Jiang, Ralph Stewart, Tony Scott, Andrew Kerr, Robyn Whittaker, Jocelyn Benatar, Anna Rolleston, Paul Estabrooks, Leila Dale. Originally published in JMIR mHealth and uHealth (https://mhealth.jmir.org), 09.06.2021. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR mHealth and uHealth, is properly cited. The complete bibliographic information, a link to the original publication on https://mhealth.jmir.org/, as well as this copyright and license information must be included.
spellingShingle Original Paper
Maddison, Ralph
Jiang, Yannan
Stewart, Ralph
Scott, Tony
Kerr, Andrew
Whittaker, Robyn
Benatar, Jocelyn
Rolleston, Anna
Estabrooks, Paul
Dale, Leila
An Intervention to Improve Medication Adherence in People With Heart Disease (Text4HeartII): Randomized Controlled Trial
title An Intervention to Improve Medication Adherence in People With Heart Disease (Text4HeartII): Randomized Controlled Trial
title_full An Intervention to Improve Medication Adherence in People With Heart Disease (Text4HeartII): Randomized Controlled Trial
title_fullStr An Intervention to Improve Medication Adherence in People With Heart Disease (Text4HeartII): Randomized Controlled Trial
title_full_unstemmed An Intervention to Improve Medication Adherence in People With Heart Disease (Text4HeartII): Randomized Controlled Trial
title_short An Intervention to Improve Medication Adherence in People With Heart Disease (Text4HeartII): Randomized Controlled Trial
title_sort intervention to improve medication adherence in people with heart disease (text4heartii): randomized controlled trial
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262599/
https://www.ncbi.nlm.nih.gov/pubmed/34106081
http://dx.doi.org/10.2196/24952
work_keys_str_mv AT maddisonralph aninterventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT jiangyannan aninterventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT stewartralph aninterventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT scotttony aninterventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT kerrandrew aninterventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT whittakerrobyn aninterventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT benatarjocelyn aninterventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT rollestonanna aninterventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT estabrookspaul aninterventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT daleleila aninterventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT maddisonralph interventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT jiangyannan interventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT stewartralph interventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT scotttony interventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT kerrandrew interventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT whittakerrobyn interventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT benatarjocelyn interventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT rollestonanna interventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT estabrookspaul interventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial
AT daleleila interventiontoimprovemedicationadherenceinpeoplewithheartdiseasetext4heartiirandomizedcontrolledtrial